Albuminuria
Information
- Disease name
- Albuminuria
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05321095 | Active, not recruiting | Screening for Albuminuria at the First Line for Early Identification of CKD | November 25, 2021 | July 2024 | |
| NCT00136773 | Completed | Phase 4 | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus | April 2003 | November 2005 |
| NCT06374043 | Completed | Phase 4 | Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. | May 11, 2021 | September 13, 2022 |
| NCT01564966 | Completed | Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation | April 2008 | December 2011 | |
| NCT01989754 | Completed | Phase 4 | A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus | January 16, 2014 | February 23, 2017 |
| NCT02020785 | Completed | N/A | Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23 | January 2014 | September 2015 |
| NCT02144740 | Completed | N/A | Effect of NWT-03 on Blood Pressure | October 2013 | |
| NCT02376075 | Completed | Phase 3 | Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria | January 2013 | September 2014 |
| NCT02446548 | Completed | N/A | Influence of Aliskiren on Albuminuria After Kidney Transplantation | March 2013 | November 2014 |
| NCT02497300 | Completed | Phase 2 | Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease | March 2015 | July 2021 |
| NCT02689778 | Completed | Phase 3 | Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy | March 2016 | December 2019 |
| NCT02945969 | Completed | Phase 3 | Sodium Lowering and Urinary Protein Reduction Trial | November 2016 | January 2021 |
| NCT03015480 | Completed | N/A | Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes | February 13, 2017 | November 25, 2018 |
| NCT03118739 | Completed | Phase 2 | Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria | May 18, 2017 | August 13, 2018 |
| NCT03396328 | Completed | N/A | Effects of Intensive Low-Salt Diet Education by Mobile Application on Albuminuria | May 10, 2018 | May 12, 2020 |
| NCT03470701 | Completed | N/A | Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit | March 19, 2018 | June 19, 2018 |
| NCT03667300 | Completed | Phase 2 | Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency | March 16, 2017 | May 14, 2019 |
| NCT03889236 | Completed | N/A | Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. | May 3, 2018 | September 9, 2020 |
| NCT04626271 | Completed | N/A | Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands | August 31, 2020 | October 25, 2020 |
| NCT04635670 | Completed | N/A | Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes | June 29, 2020 | November 8, 2022 |
| NCT04889183 | Completed | Phase 3 | SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes | March 14, 2022 | May 28, 2024 |
| NCT05838872 | Completed | N/A | Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User Hands | December 9, 2021 | July 15, 2022 |
| NCT00095290 | Completed | Phase 4 | Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria | September 2004 | November 2005 |
| NCT00214825 | Completed | N/A | Aldosterone and Vascular Disease in Diabetes Mellitus | August 2003 | March 2006 |
| NCT00312780 | Completed | Phase 2 | Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy | March 2006 | December 2007 |
| NCT00524992 | Completed | Evaluation of Albuminuria HIV-Infected Patients | August 29, 2007 | December 24, 2014 | |
| NCT00625820 | Completed | Phase 2 | Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria | May 2008 | September 2008 |
| NCT01041599 | Completed | Correlation of Albuminuria With Arterial Stiffness | October 2009 | February 2012 | |
| NCT01071785 | Completed | N/A | Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS) | June 2007 | December 2009 |
| NCT01375322 | Completed | Phase 4 | ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria | June 2007 | June 2010 |
| NCT01436747 | Completed | Phase 3 | Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients | July 2012 | July 2015 |
| NCT01547897 | Completed | Phase 2 | NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria | March 2012 | December 2013 |
| NCT06094920 | Not yet recruiting | Phase 4 | Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial | May 1, 2024 | October 1, 2024 |
| NCT06147232 | Not yet recruiting | Phase 4 | Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia | August 2024 | June 2036 |
| NCT04916132 | Recruiting | Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors | August 10, 2021 | December 31, 2043 | |
| NCT04752293 | Recruiting | Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | May 19, 2021 | December 2025 | |
| NCT05286632 | Recruiting | N/A | KidneYou - Innovative Digital Therapy | July 18, 2022 | June 2024 |
| NCT00342927 | Recruiting | Family Investigation of Nephropathy and Diabetes (F.I.N.D.) | March 7, 2001 | ||
| NCT05498116 | Recruiting | Phase 4 | Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | January 26, 2023 | October 2025 |
| NCT05881447 | Recruiting | Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa | June 21, 2023 | December 31, 2025 | |
| NCT03201939 | Suspended | Phase 2 | Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria | July 1, 2024 | February 2025 |
| NCT00961207 | Terminated | Phase 4 | Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients | August 2009 | September 2012 |
| NCT05268926 | Terminated | Phase 2 | TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension | February 3, 2022 | February 2, 2023 |
| NCT00208221 | Terminated | Phase 3 | Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes | August 2006 | June 2007 |
| NCT02417571 | Unknown status | N/A | Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKD | April 2015 | December 2019 |
| NCT04295889 | Unknown status | N/A | Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches | November 14, 2019 | July 1, 2022 |
| NCT00263419 | Unknown status | N/A | Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes | January 2005 | June 2012 |
| NCT01316068 | Unknown status | Phase 4 | Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients | March 2011 | August 2012 |
| NCT03622957 | Unknown status | Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes | August 10, 2018 | September 3, 2018 | |
| NCT00202618 | Unknown status | Phase 4 | Rationale and Design for Shiga Microalbuminuria Reduction Trial | December 2003 | June 2006 |
| NCT04073927 | Unknown status | N/A | Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal Inflammation | August 5, 2019 | August 5, 2020 |
| NCT04272359 | Unknown status | Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus | May 6, 2019 | December 31, 2021 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0012592
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000419